Terms: = Breast cancer AND Ki-67 AND Prognosis
929 results:
1. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
Qi G; Zhang X; Gai X; Yan X
PeerJ; 2024; 12():e17377. PubMed ID: 38766488
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of ki-67 proliferative index with oncotype DX recurrence score in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer with low-burden axillary nodal disease - a review of 137 cases.
Saad Abdalla Al-Zawi A; Anichkina KA; Elamass M; Aladili Z
Pol J Pathol; 2024; 75(1):8-18. PubMed ID: 38741425
[TBL] [Abstract] [Full Text] [Related]
3. Artificial intelligence-powered optimization of ki-67 assessment in breast cancer: enhancing precision and workflow efficiency. a literature review.
Mooghal M; Anjum S; Khan W; Tariq H; Babar A; Vohra LM
J Pak Med Assoc; 2024 Apr; 74(4 (Supple-4)):S109-S116. PubMed ID: 38712418
[TBL] [Abstract] [Full Text] [Related]
4. Lesion attention guided neural network for contrast-enhanced mammography-based biomarker status prediction in breast cancer.
Qian N; Jiang W; Wu X; Zhang N; Yu H; Guo Y
Comput Methods Programs Biomed; 2024 Jun; 250():108194. PubMed ID: 38678959
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Pregnancy on breast cancer Features and prognosis.
Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
[TBL] [Abstract] [Full Text] [Related]
6. Effect of tumor-infiltrating immune cells (mast cells, neutrophils and lymphocytes) on neoadjuvant chemotherapy response in breast carcinomas.
Okcu O; Öztürk Ç; Yalçın N; Yalçın AC; Şen B; Aydın E; Öztürk AE
Ann Diagn Pathol; 2024 Jun; 70():152301. PubMed ID: 38581761
[TBL] [Abstract] [Full Text] [Related]
7. Case report: A case of Paget disease outside the axillary breast.
Zhou Z; Zhou B; Wu X; Wei W
Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of Clinicopathological Features of Pleomorphic and Invasive Lobular breast Carcinomas.
Sağdıç MF; Güler OC; Subaşı O; Albayrak Ö; Özaslan C
Am Surg; 2024 Jun; 90(6):1383-1389. PubMed ID: 38513191
[TBL] [Abstract] [Full Text] [Related]
9. [A Case of breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
10. The small nucleolar RNA SNORA51 enhances breast cancer stem cell-like properties via the RPL3/NPM1/c-MYC pathway.
Li S; Jin Z; Song X; Ma J; Peng Z; Yu H; Song J; Zhang Y; Sun X; He M; Yu X; Jin F; Zheng A
Mol Carcinog; 2024 Jun; 63(6):1117-1132. PubMed ID: 38421204
[TBL] [Abstract] [Full Text] [Related]
11. Accuracy of cytological grading in the carcinoma breast and its correlation with pathological prognostic parameters.
Chauhan D; Sahu N; Sahoo SR; Senapati U
J Cancer Res Ther; 2023 Oct; 19(7):1956-1961. PubMed ID: 38376303
[TBL] [Abstract] [Full Text] [Related]
12. ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in breast cancer.
Yang ZG; Ren LH; Wang F; Wang PL; Wang WY; Lin SY
Curr Med Sci; 2024 Feb; 44(1):156-167. PubMed ID: 38302780
[TBL] [Abstract] [Full Text] [Related]
13. Solid basal adenoid cystic carcinoma of the breast: A case report and literature review.
Gou WB; Yang YQ; Song BW; He P
Medicine (Baltimore); 2024 Jan; 103(3):e37010. PubMed ID: 38241532
[TBL] [Abstract] [Full Text] [Related]
14. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer.
Wang W; Lei W; Fang Z; Jiang R; Wang X
BMC Cancer; 2024 Jan; 24(1):1. PubMed ID: 38166784
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy.
Shao Y; Guan H; Luo Z; Yu Y; He Y; Chen Q; Liu C; Zhu F; Liu H
Breast; 2024 Feb; 73():103666. PubMed ID: 38159433
[TBL] [Abstract] [Full Text] [Related]
17. Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for ki-67 in breast cancer.
Arora R; Alam F; Zaka-Ur-Rab A; Maheshwari V; Alam K; Hasan M
J Egypt Natl Canc Inst; 2023 Dec; 35(1):43. PubMed ID: 38143264
[TBL] [Abstract] [Full Text] [Related]
18. Validation of CTS5 Model in Large-scale breast cancer Population and Combination of CTS5 and ki-67 Status to Develop a Novel Nomogram for prognosis Prediction.
Ning L; Liu Y; He X; Han R; Xin Y; Zhao J; Liu X
Am J Clin Oncol; 2024 May; 47(5):228-238. PubMed ID: 38131531
[TBL] [Abstract] [Full Text] [Related]
19. [The expression of Plakoglobin in residual cancer after neoadjuvant chemotherapy for breast cancer and its prognostic impact on patients].
Li Y; Guo L; Guo CY; Lei CQ; Zhang K; Wang NC; Wang ZZ; Xuan LX
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1057-1064. PubMed ID: 38110314
[No Abstract] [Full Text] [Related]
20. The Clinicopathological Features and Prognostic Significance of HER2-Low in Early breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative breast cancer Stratified by Hormone Receptor Status.
Gamrani S; Akhouayri L; Boukansa S; Karkouri M; El Fatemi H
Breast J; 2023; 2023():6621409. PubMed ID: 38075551
[TBL] [Abstract] [Full Text] [Related]
[Next]
